Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) FCF Margin (2016 - 2025)

Historic FCF Margin for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 39.25%.

  • Utah Medical Products' FCF Margin rose 16000.0% to 39.25% in Q3 2025 from the same period last year, while for Sep 2025 it was 35.93%, marking a year-over-year decrease of 24400.0%. This contributed to the annual value of 35.7% for FY2024, which is 73900.0% down from last year.
  • Utah Medical Products' FCF Margin amounted to 39.25% in Q3 2025, which was up 16000.0% from 28.35% recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' FCF Margin registered a high of 54.89% during Q1 2023, and its lowest value of 25.5% during Q2 2024.
  • Over the past 5 years, Utah Medical Products' median FCF Margin value was 39.25% (recorded in 2025), while the average stood at 39.52%.
  • Its FCF Margin has fluctuated over the past 5 years, first tumbled by -113500bps in 2022, then skyrocketed by 158600bps in 2023.
  • Utah Medical Products' FCF Margin (Quarter) stood at 36.66% in 2021, then grew by 13bps to 41.56% in 2022, then grew by 2bps to 42.5% in 2023, then decreased by -25bps to 31.98% in 2024, then grew by 23bps to 39.25% in 2025.
  • Its last three reported values are 39.25% in Q3 2025, 28.35% for Q2 2025, and 44.08% during Q1 2025.